Close Menu

NEW YORK (GenomeWeb) – Germany's Merck KGaA reported today that its revenues for fiscal year 2015 climbed 13 percent year over year, driven by growth in its life science segment and including the contribution of Sigma-Aldrich.

Sales for the life science segment jumped 25 percent year over year to €3.36 billion ($3.71 billion) from €2.68 billion. Within that segment, the company's process solutions business had sales of €1.43 billion, while sales for its lab solutions business were around €1.20 billion, and revenues for the bioscience business area were €450 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.